Emergent BioSolutions Inc...

NYSE: EBS · Real-Time Price · USD
9.07
0.23 (2.60%)
At close: Aug 18, 2025, 3:59 PM
8.90
-1.92%
After-hours: Aug 18, 2025, 07:46 PM EDT

Emergent BioSolutions Revenue

Emergent BioSolutions reported an annual revenue of $1.01B, reflecting a -3.4% growth. For the quarter ending June 30, 2025, Emergent BioSolutions generated $140.9M in revenue.
Revenue (ttm)
1.01B
Revenue Growth
-3.4%
Price / Sales Ratio
0.5
Revenue / Employee
1.13M
Employees
900
Market Cap
484.16M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 1.01B -3.40%
Dec 31, 2023 1.05B -6.39%
Dec 31, 2022 1.12B -37.47%
Dec 31, 2021 1.79B +15.26%
Dec 31, 2020 1.56B +40.63%
Dec 31, 2019 1.11B +41.36%
Dec 31, 2018 782.4M +39.50%
Dec 31, 2017 560.87M +14.75%
Dec 31, 2016 488.78M -6.50%
Dec 31, 2015 522.79M +16.14%
Dec 31, 2014 450.14M +43.93%
Dec 31, 2013 312.75M +10.95%
Dec 31, 2012 281.89M +3.11%
Dec 31, 2011 273.38M -4.47%
Dec 31, 2010 286.17M +21.89%
Dec 31, 2009 234.79M +31.49%
Dec 31, 2008 178.55M -2.38%
Dec 31, 2007 182.91M +19.76%
Dec 31, 2006 152.73M +16.87%
Dec 31, 2005 130.69M +56.52%
Dec 31, 2004 83.49M +49.71%
Dec 31, 2003 55.77M -28.99%
Dec 31, 2002 78.54M +73.35%
Dec 31, 2001 45.31M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.